BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2000
View Archived Issues
At least 50% of patients experience clinical benefit with Vasogen's psoriasis candidate
Read More
Long-acting formulation of Amylin's diabetes Rx nears clinical trials
Read More
Positive phase IIa outcome reported for Xenova's XR-9576
Read More
Antisense compound from Isis enters phase III clinical testing
Read More
Pain Therapeutics begins phase II opioid pain medication trial
Read More
Cancer antigen discovery agreement signed by Genzyme Molecular Oncology and Purdue
Read More
HIV vaccine program at Panacos boosted by NIH grant
Read More
ArQule and Genome Therapeutics step up drug discovery collaboration
Read More
Cortex to study AMPAKINE stroke therapy under NIH grant
Read More
IND for hepatitis C gene fusion therapy submitted by Human Genome Sciences
Read More
New camptothecin derivative examined for safety, pharmacokinetics on various dosing schedules
Read More
MDR-reversing effects of MS-209 investigated in laboratory and animal experiments
Read More
TZT-1027 possesses additional antiangiogenic activity according to several recent studies
Read More
New squalene synthase inhibitor compares favorably to pravastatin and fenofibrate
Read More
NO-releasing paracetamol derivative exerts both analgesic and antiinflammatory effects
Read More
CHAP-based histone deacetylase inhibitors with antitumor activity presented at recent meeting
Read More
Novel theory of depression may lead to new therapeutic strategies
Read More
Sensory nerve sodium channel blocker shows potential in neuropathic pain
Read More
Pyrimidines prepared at AstraZeneca show inhibition of cell cycle kinases
Read More
Novel serotonergic diazole derivatives from AHP useful in depression and anxiety
Read More
Taisho presents new series of vasodilators
Read More
CHT-22: a new antitumor substance produced by Streptomyces
Read More
Sagami isolates novel antitumor agents from marine organism
Read More
Novel nicotinic receptor subtype-selective agents useful for CNS and GI disorders
Read More
Androgenic steroids with opposite configuration to natural products claimed by Azko Nobel
Read More
Inhibitors of protein-tyrosine-phosphatase in the Pharmacia pipeline
Read More
SB reports discovery of CCR3 receptor antagonists and potential applications thereof
Read More
The menace of antibacterial resistance
Read More